Drugs / Ta-NPs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07578506 | May → Dec 2026 expected | retroperitoneal sarcoma | West China Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ta-NPs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07578506 ↗ |